Avalon GloboCare

Avalon GloboCare Corp. is a leading clinical-stage CellTech biodeveloper dedicated to advancing and empowering innovative, transformative immune effector cell therapies. Avalon also provides strategic consulting and outsourcing services to facilitate and enhance its clients' growth, development, and competitiveness in the healthcare and CellTech industry markets.Avalon’s subsidiary and joint venture structure enhances investor flexibility and R&D focus, enabling Avalon to establish a leadership position in the fields of immune effector cell therapies (including CAR-T and CAR-NK), exosome-based regenerative therapies (our ACTEX™ platform), and "liquid biopsy" diagnostics.